Concepedia

Vivek S. Purohit

VS

Statistics

Publications

31

Citations

1.7K

H-Index

20

Active since

2003

Affiliations

Pfizer (United States)(Current)

University at Buffalo, State University of New York

Pfizer (United Kingdom)

Roswell Park Comprehensive Cancer Center

Innovaderm (Canada)

Vivek S. Purohit is an author at Pfizer (United States) specializing in pharmacology, medicine, and clinical pharmacology.

ORCID

Publications per year

2003–2024

31

Publications

31

Topical tofacitinib for atopic dermatitis: a phase <scp>II</scp> a randomized trial

Robert Bissonnette, Kim Papp, Yves Poulin et al. · British Journal of Dermatology · 2016 · 418 citations · Full text

, , +15

Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial

Brett King, Xingqi Zhang, Walter Gubelin Harcha et al. · The Lancet · 2023 · 261 citations · Full text

, , +7

Crisaborole and atopic dermatitis skin biomarkers: An intrapatient randomized trial

Robert Bissonnette, Ana B. Pavel, Aisleen Diaz et al. · Journal of Allergy and Clinical Immunology · 2019 · 124 citations · Full text

, , +14

Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial

Kim Papp, Robert Bissonnette, Melinda Gooderham et al. · BMC Dermatology · 2016 · 98 citations · Full text

, , +11

Influence of aggregation on immunogenicity of recombinant human Factor VIII in hemophilia A mice

Vivek S. Purohit, C. Russell Middaugh, Sathyamangalam V. Balasubramanian · Journal of Pharmaceutical Sciences · 2005 · 94 citations · Full text

, , +14

1–5 of 31